Initially, anti-Caspr antibodies have been found in one patient with CIDP and another patient with GBS, both of whom had very severe pain that necessitated treatment with high dose pregabalin and opioids as a distinguishing feature (Table 5) (46). The gene discussed is CNTNAP1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.